Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00759980 · ClinicalTrials.gov registry record
Transfusing Neonates Based on Platelet Mass
A clinical trial, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- 50
- Enrollment target
NCT00759980 is a clinical trial that has completed, run by Christiana Care Health Services. The registered enrollment target is 50 participants.
The verdict
NCT00759980 has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Thrombocytopenia (low platelet count) is common in the neonatal intensive care unit. Commonly, the decision of when to transfuse platelets is based on platelet number. Recently, Christensen et al (2006) proposed using transfusion guidelines based on platelet mass rather than platelet number. By using platelet size as a guide of when to give platelets, we may be able to decrease the amount platelet transfusions needed. This study is investigating using platelet size rather than platelet number as a guideline for transfusing platelets in infants who are hospitalized in a NICU (neonatal intensive care unit). After obtaining parental informed consent, thrombocytopenic infants will be randomized to one of two groups. 1: Transfusion based on platelet number; 2: transfusion based on a combination of platelet number and platelet mass. In each group the decision to transfuse platelets will be made using a slightly different, yet strict set of transfusion rules. The objective is to determine the feasibility, rate of bleeding complications and compliance of transfusing neonates based on platelet mass rather than platelet number. The investigators hypothesize that transfusing platelets based on platelet mass will not increase bleeding complications and will reduce the number of transfusions in thrombocytopenic neonates.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00759980
The ClinicalTrials.gov registry entry for NCT00759980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00759980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00759980 about?
NCT00759980 is a clinical study titled "Transfusing Neonates Based on Platelet Mass". Thrombocytopenia (low platelet count) is common in the neonatal intensive care unit. Commonly, the decision of when to transfuse platelets is based on platelet number. Recently, Christensen et al (2006) proposed using transfusion guidelines based on platelet mass rather than platelet number. By usin...
What is the current status of trial NCT00759980?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2008-10. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT00759980?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.